Vir Biotechnology, Inc. · NASDAQ:VIR
De Backer Marianne sold 72,559 Vir Biotechnology, Inc. shares (Form 4)
Traded Apr 6, 2026 · Filed Apr 7, 2026
On Apr 6, 2026, De Backer Marianne (Director, President and CEO) sold 72,559 Vir Biotechnology, Inc. shares at US$9.16 for US$665K under a trading plan, leaving 948,145 shares. Filed Apr 7, 2026 (Form 4).
- Sold
- 72,559 shares
- Price
- US$9.16
- Value
- US$665K
- Holding after
- 948,145 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | Sale | 72,559 | US$9.16 | 948,145 | Direct |
Source
Related
- Vir Biotechnology, Inc.
- De Backer Marianne
- Vir Biotechnology, Inc. shareholders
- Form 4 · De Backer Marianne · Apr 30, 2026
- Form 4 · More Robert J · Aug 12, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Form 4 · Coughlin Timothy · Jun 10, 2026
- Form 4 · Napolitano Janet · Jun 2, 2026